A ‘Game Changer’ for Patients With Esophageal Cancer

The New York Times | March 31, 2021, 5:59 p.m. | Original

A drug that unleashes the immune system offers a rare glimmer of hope for those with a cancer that resists most treatments.

Some Johnson & Johnson Covid Vaccine Doses Delayed in U.S. by Factory Mix-Up Pregnancy Complications Have Been Common During the Pandemic, Researchers Say